HDAC9 and Familial prostate cancer: This suggests that the MTA1/HDAC complex regulates negatively the PTEN, and thus promotes proliferation as well as metastasis of prostate cancer, and that RVT can abrogate these key oncogenic hallmarks through the inhibition of MTA1 [54].